MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1

Medical Oncology

Volumn 31, Issue 3, 2014, Pages

  Yan, Jiang ^a   Guo, Xiaoqiang ^a   Xia, Jiazeng ^a   Shan, Tin ^a   Gu, Chen ^a   Liang, Zheng ^a   Zhao, Wei ^a   Jin, Shimao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

DNMT 1; Hypermethylation; MEG3; miR 148a

Indexed keywords

DNA METHYLTRANSFERASE 1; GENOMIC DNA; LONG UNTRANSLATED RNA; MEG3; MICRORNA; MICRORNA 148A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; MEG3 NON CODING RNA, HUMAN; MEG3 NON-CODING RNA, HUMAN; MESSENGER RNA; MIRN148 MICRORNA, HUMAN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADICAL RESECTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; STOMACH CANCER; TUMOR SUPPRESSOR GENE; CELL PROLIFERATION; COMPARATIVE STUDY; GENETICS; METABOLISM; PATHOLOGY; PROGNOSIS; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH; STOMACH TUMOR; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL PROLIFERATION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PROGNOSIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; RNA, MESSENGER; STOMACH; STOMACH NEOPLASMS;

EID: 84893181818     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0879-6     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. doi: 10.3322/caac.20107.
2. Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 2012;31(43):4577-87. doi: 10.1038/onc.2011.621.
3. Wylie AA, Murphy SK, Orton TC, Jirtle RL. Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation. Genome Res. 2000;10(11):1711-8.
4. Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab. 2003;88(11):5119-26. doi: 10.1210/jc.2003-030222.
5. Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, et al. Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma. PLoS ONE. 2012;7(11):e49462. doi: 10.1371/journal. pone.0049462.
6. Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu WQ, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer. 2013;13:461. doi: 10.1186/1471-2407-13-461.
7. Ying L, Huang Y, Chen H, Wang Y, Xia L, Chen Y, et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol BioSyst. 2013;9(3):407-11. doi: 10.1039/c2mb25386k.
8. Kawakami T, Chano T, Minami K, Okabe H, Okada Y, Okamoto K. Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma. Hum Mol Genet. 2006;15(6):821-30.
9. Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res. 2010;70(6):2350-8. doi: 10.1158/0008-5472.CAN-09-3885.
10. Hu YC, Yang ZH, Zhong KJ, Niu LJ, Pan XJ, Wu DC, et al. Alteration of transcriptional profile in human bronchial epithelial cells induced by cigarette smoke condensate. Toxicol Lett. 2009;190(1):23-31. doi: 10.1016/j.toxlet.2009. 06.860.
11. Katrincsakova B, Takeda H, Urbankova H, Michaux L, Jarosova M, Vandenberghe P, et al. Methylation analysis of the imprinted DLK1-GTL2 domain supports the random parental origin of the IGH-involving del(14q) in B-cell malignancies. Epigenetics. 2009;4(7):469-75.
12. Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350- 5. doi: 10.1038/nature02871.
13. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215-33. doi: 10.1016/j.cell.2009.01.002.
14. Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell. 2012;148(6):1172-87. doi: 10.1016/j.cell.2012.02.005.
15. Wei B, Song Y, Zhang Y, Hu M. microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2. Oncol Lett. 2013;6(6):1713-8. doi: 10.3892/ol.2013.1609.
16. Zhang J, Kuai X, Song M, Chen X, Yu Z, Zhang H, et al. microRNA-32 inhibits the proliferation and invasion of the SGC-7901 gastric cancer cell line. Oncol Lett. 2014;7(1):270-4. doi: 10.3892/ol.2013.1667.
17. Song F, Yang D, Liu B, Guo Y, Zheng H, Li L, et al. Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family. Clin Cancer Res. 2013;. doi: 1078-0432.
18. Zhu A, Xia J, Zuo J, Jin S, Zhou H, Yao L, et al. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer. Med Oncol. 2012;29(4):2701-9. doi: 10.1007/s12032-011-0134-3.
19. Zuo J, Xia J, Ju F, Yan J, Zhu A, Jin S, et al. MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancer. Mol Cells. 2013;35(4):313-9. doi: 10.1007/s10059-013-2314-9.
20. Hubertus J, Lacher M, Rottenkolber M, Muller-Hocker J, Berger M, Stehr M, et al. Altered expression of imprinted genes in Wilms tumors. Oncol Rep. 2011;25(3):817-23. doi: 10.3892/or.2010.1113.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402-8. doi: 10.1006/meth.2001.1262.
22. Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013;152(6):1298-307. doi: 10.1016/j.cell.2013. 02.012.
23. Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013;52(1):101-12. doi: 10.1016/j.molcel.2013.08.027.
24. Chiyomaru T, Yamamura S, Fukuhara S, Yoshino H, Kinoshita T, Majid S, et al. Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR. PLoS ONE. 2013;8(8):e70372. doi: 10.1371/journal.pone.0070372.
25. Sun M, Xia R, Jin F, Xu T, Liu Z, De W, et al. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol. 2013;. doi: 10.1007/s13277-013- 1142-z.
26. McMurray EN, Schmidt JV. Identification of imprinting regulators at the Meg3 differentially methylated region. Genomics. 2012;100(3):184-94. doi: 10.1016/j.ygeno.2012.06.001.
27. Qu C, Jiang T, Li Y, Wang X, Cao H, Xu H, et al. Gene expression and IG-DMR hypomethylation of maternally expressed gene 3 in developing corticospinal neurons. Gene Expr Patterns. 2013;13(1-2):51-6. doi: 10.1016/j.gep.2012.11.003.
28. Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S, et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene. 2011;30(47):4750-6. doi: 10.1038/onc.2011.193.
29. Tseng CW, Lin CC, Chen CN, Huang HC, Juan HF. Integrative network analysis reveals active microRNAs and their functions in gastric cancer. BMC Syst Biol. 2011;5:99. doi: 10.1186/1752-0509-5-99.